Cationic gelatin nanoparticles for drug delivery to the ocular surface: In vitro and in vivo evaluation

Journal of Nanomaterials

Volumn 2013, Issue , 2013, Pages

  Tseng, Ching Li ^a   Chen, Ko Hua ^b,c,d   Su, Wen Yu ^b,e,f   Lee, Yen Hsien ^b,g   Wu, Chi Chang ^a   Lin, Fen Huei ^b,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CYTOLOGY; DRUG DELIVERY; FLUORESCENCE; NANOPARTICLES;

COLLOIDAL CARRIERS; CORNEAL THICKNESS; FLUORESCENCE INTENSITIES; GELATIN NANOPARTICLES; NEGATIVELY CHARGED; NEW ZEALAND RABBITS; OCULAR DRUG DELIVERY; POSITIVELY CHARGED;

CELLS;

EID: 84896139265     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2013/238351     Document Type: Article

References (35)

1. Torchilin V. P., Trubetskoy V. S., Which polymers can make nanoparticulate drug carriers long-circulating? Advanced Drug Delivery Reviews 1995 16 2-3 141 155 2-s2.0-0029360322 10.1016/0169-409X(95)00022-Y
2. Binstock E. E., Domb A. J., Domb A. J., Tabata Y., Kumar M. N. V. R., Farber S., Nanoparticles in locular drug delivery. Nanoparticles for Pharmaceutical Applications 2007 Valencia, Calif, USA American Scientific Publishers 367 376
3. Davies N. M., Biopharmaceutical considerations in topical ocular drug delivery. Clinical and Experimental Pharmacology and Physiology 2000 27 7 558 562 2-s2.0-0034045780 10.1046/j.1440-1681.2000.03288.x (Pubitemid 30418006)
4. Diebold Y., Jarrín M., Sáez V., Carvalho E. L. S., Orea M., Calonge M., Seijo B., Alonso M. J., Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 2007 28 8 1553 1564 2-s2.0-33845891058 10.1016/j.biomaterials.2006.11.028 (Pubitemid 46027250)
5. de Campos A. M., Sánchez A., Alonso M. J., Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. International Journal of Pharmaceutics 2001 224 1-2 159 168 2-s2.0-0035859983 10.1016/S0378-5173(01)00760-8 (Pubitemid 32706495)
6. Bourges J.-L., Gautier S. E., Delie F., Bejjani R. A., Jeanny J.-C., Gurny R., BenEzra D., Behar-Cohen F. F., Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Investigative Ophthalmology & Visual Science 2003 44 8 3562 3569 2-s2.0-0042844771 10.1167/iovs.02-1068 (Pubitemid 36909796)
7. de la Fuente M., Seijo B., Alonso M. J., Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Investigative Ophthalmology & Visual Science 2008 49 5 2016 2024 2-s2.0-44649113307 10.1167/iovs.07-1077
8. Başaran E., Demirel M., Sirmagül B., Yazan Y., Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. Journal of Microencapsulation 2010 27 1 37 47 2-s2.0-75449109191 10.3109/02652040902846883
9. Kawashima Y., Yamamoto H., Takeuchi H., Kuno Y., Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharmaceutical Development and Technology 2000 5 1 77 85 2-s2.0-0033969945 10.1081/PDT-100100522 (Pubitemid 30069202)
10. Gökçe E. H., Sandri G., Erilmez S., Bonferoni M. C., Güneri T., Caramella C., Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes. Current Eye Research 2009 34 11 996 1003 2-s2.0-72449183701 10.3109/02713680903261405
11. Djagny K. B., Wang Z., Xu S., Gelatin: a valuable protein for food and pharmaceutical industries: review. Critical Reviews in Food Science and Nutrition 2001 41 6 481 492 2-s2.0-0034814202 (Pubitemid 32931338)
12. Sintzel M. B., Bernatchez S. F., Tabatabay C., Gurny R., Biomaterials in ophthalmic drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 1996 42 6 358 374 2-s2.0-0030357502 (Pubitemid 27490453)
13. Sham J. O.-H., Zhang Y., Finlay W. H., Roa W. H., Löbenberg R., Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. International Journal of Pharmaceutics 2004 269 2 457 467 2-s2.0-0347360189 10.1016/j.ijpharm.2003.09.041 (Pubitemid 38045308)
14. Kaul G., Amiji M., Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharmaceutical Research 2005 22 6 951 961 2-s2.0-21244448447 10.1007/s11095-005-4590-3 (Pubitemid 40898105)
15. Gupta A. K., Gupta M., Yarwood S. J., Curtis A. S. G., Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts. Journal of Controlled Release 2004 95 2 197 207 2-s2.0-1242293735 10.1016/j.jconrel.2003.11.006 (Pubitemid 38230035)
16. Tseng C.-L., Su W.-Y., Yen K.-C., Yang K.-C., Lin F.-H., The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009 30 20 3476 3485 2-s2.0-67349255031 10.1016/j.biomaterials.2009.03.010
17. Vandervoort J., Ludwig A., Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. European Journal of Pharmaceutics and Biopharmaceutics 2004 57 2 251 261 2-s2.0-1442310826 10.1016/S0939-6411(03)00187-5 (Pubitemid 38283701)
18. Zorzi G. K., Contreras-Ruiz L., Párraga J. E., López-García A., Romero Bello R., Diebold Y., Seijo B., Sánchez A., Expression of MUC5AC in ocular surface epithelial cells using cationized gelatin nanoparticles. Molecular Pharmaceutics 2011 8 5 1783 1788 2-s2.0-80053545182 10.1021/mp200155t
19. Nagarwal R. C., Kant S., Singh P. N., Maiti P., Pandit J. K., Polymeric nanoparticulate system: a potential approach for ocular drug delivery. Journal of Controlled Release 2009 136 1 2 13 2-s2.0-67349084376 10.1016/j.jconrel.2008. 12.018
20. Coester C. J., Langer K., Von Briesen H., Kreuter J., Gelatin nanoparticles by two step desolvation-a new preparation method, surface modifications and cell uptake. Journal of Microencapsulation 2000 17 2 187 193 2-s2.0-0034092776 (Pubitemid 30135796)
21. Tseng C.-L., Lin F.-H., Preparation of gelatin nanoparticles with EGFR selection ability via biotinylated-EGF conjugation for lung cancer targeting. Biomedical Engineering: Applications, Basis and Communications 2008 20 3 161 169 2-s2.0-56549129583
22. Smith J., Wood E., Dornish M., Effect of chitosan on epithelial cell tight junctions. Pharmaceutical Research 2004 21 1 43 49 2-s2.0-1642579659 10.1023/B:PHAM.0000012150.60180.e3 (Pubitemid 38122290)
23. Test Guideline 405: Acute Eye Irritation/Corrosion 2002 Organization for Economic Co-Operation and Development
24. Lai J.-Y., Biocompatibility of chemically cross-linked gelatin hydrogels for ophthalmic use. Journal of Materials Science: Materials in Medicine 2010 21 6 1899 1911 2-s2.0-77954521505 10.1007/s10856-010-4035-3
25. Hsu W. M., Chen K. H., Lai J. Y., Hsiue G., Transplantation of human corneal endothelial cells using functional biomaterials: poly(N- isopropylacrylamide) and gelatin. Journal of Experimental & Clinical Medicine 2013 5 2 56 64
26. van der Bijl P., Engelbrecht A. H., van Eyk A. D., Meyer D., Comparative permeability of human and rabbit corneas to cyclosporin and tritiated water. Journal of Ocular Pharmacology and Therapeutics 2002 18 5 419 427 2-s2.0-0036779689 (Pubitemid 37420251)
27. Young S., Wong M., Tabata Y., Mikos A. G., Gelatin as a delivery vehicle for the controlled release of bioactive molecules. Journal of Controlled Release 2005 109 1-3 256 274 2-s2.0-28444469746 10.1016/j.jconrel.2005.09.023 (Pubitemid 41737269)
28. de Campos A. M., Diebold Y., Carvalho E. L. S., Sánchez A., Alonso M. J., Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharmaceutical Research 2004 21 5 803 810 2-s2.0-3543046202 10.1023/B:PHAM.0000026432.75781.cb (Pubitemid 39011304)
29. de Salamanca A. E., Diebold Y., Calonge M., García-Vazquez C., Callejo S., Vila A., Alonso M. J., Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Investigative Ophthalmology & Visual Science 2006 47 4 1416 1425 2-s2.0-33645999705 10.1167/iovs.05-0495 (Pubitemid 46780748)
30. de Campos A. M., Sánchez A., Gref R., Calvo P., Alonso M. J., The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. European Journal of Pharmaceutical Sciences 2003 20 1 73 81 2-s2.0-0042834363 10.1016/S0928-0987(03)00178-7 (Pubitemid 37103234)
31. Mannermaa E., Vellonen K.-S., Urtti A., Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Advanced Drug Delivery Reviews 2006 58 11 1136 1163 2-s2.0-33751172725 10.1016/j.addr.2006.07.024
32. Rabinovich-Guilatt L., Couvreur P., Lambert G., Dubernet C., Cationic vectors in ocular drug delivery. Journal of Drug Targeting 2004 12 9-10 623 633 2-s2.0-11944267744 10.1080/10611860400015910 (Pubitemid 40100710)
33. Hutak C. M., Jacaruso R. B., Ik R., Evaluation of primary ocular irritation: alternatives to the Draize test. Ocular Therapeutics and Drug Delivery 1996 Lancaster, Pa, USA Technomic Publishing
34. Guo L., Moss S. E., Alexander R. A., Ali R. R., Fitzke F. W., Cordeiro M. F., Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Investigative Ophthalmology & Visual Science 2005 46 1 175 182 2-s2.0-11144297629 10.1167/iovs.04-0832 (Pubitemid 40041195)
35. Yenice I., Mocan M. C., Palaska E., Bochot A., Bilensoy E., Vural I., Irkeç M., Atilla Hincal A., Hyaluronic acid coated poly- ε -caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea. Experimental Eye Research 2008 87 3 162 167 2-s2.0-50849099475 10.1016/j.exer.2008.04.002